UK-based spine device company raises $3.1M, will use funds to launch devices in US

U.K.-based Axis Spine Technologies closed a $3.1 million (£2.2 million) funding round, Finsmes reported Feb. 24.

Advertisement

ACF Investors’ Delta Fund led the round with participation from Mercia’s EIS fund. Simon Cartmell also led a solo investment.

Axis Spine Technologies will use the funds to launch devices in the U.S. and further develop its Oblique and Lateral cage implant systems.

The Axis-ALIF received FDA-clearance in May 2020, and the first surgery was completed with the devices in Atlanta in November 2020.

Note: Conversion from pound to USD was current as of Feb. 24.

More articles on surgery centers:
Amazon’s healthcare moves: 7 notes for ASCs and physicians
What ASC management company had the best 2020? & more — 9 ASC industry notes
3 joint-venture ASCs opened or announced in January

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.